Aristeia Capital’s Fusion Acquisition Corp. II Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share FSNB.WS Stock Holding History
Bought
Maintained
Sold
Other funds holding FSNB.WS
RCM
SCM
SIA
ETH
GAM
SBLIC
DCM
SMA
RCM
Aristeia Capital's FSNB.WS Position: Q4 2022 in Review
Aristeia Capital sold out of Fusion Acquisition Corp. II Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share (FSNB.WS) in Q4 2022, closing a stake of 960,348 shares — an estimated $62K sold.
Aristeia Capital first reported a position in FSNB.WS in Q3 2021 and held it in 5 quarters. The position peaked at $189K in Q1 2022. 15 funds tracked by Wall St. Rank hold FSNB.WS as of Q4 2022.
- Aristeia Capital reported no remaining Fusion Acquisition Corp. II Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share position as of Q4 2022 after selling out during the quarter.
- Aristeia Capital sold 960,348 Fusion Acquisition Corp. II Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share shares in Q4 2022, an estimated $62K.
- Aristeia Capital first reported a position in Fusion Acquisition Corp. II Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share in Q3 2021 and held it in 5 quarters.
- Aristeia Capital's Fusion Acquisition Corp. II Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share position peaked at $189K in Q1 2022.
- 15 funds tracked by Wall St. Rank held Fusion Acquisition Corp. II Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share as of Q4 2022.
Based on Aristeia Capital's 13F filing for Q4 2022, filed 14 Feb 2023.